Physician profile
William Langhorne
NPI 1386644813
$604.58
in general payments reported to CMS, 2019-2025
12 companies · $50.82 in 2025
The $50.82 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $68.63 · 2020: $106 · 2021: $32.90 · 2022: $96.65 · 2023: $112 · 2024: $138 · 2025: $50.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $300.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $131.65 | 2021-2023 | Watchman Access System |
| Amgen INC. | $94.15 | 2020-2024 | Repatha |
| Baxter Healthcare | $82.64 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| E.R. Squibb & Sons, L.L.C. | $82.01 | 2022-2025 | Eliquis, Camzyos |
| Pfizer INC. | $42.83 | 2019-2025 | |
| Medtronic Vascular, INC. | $42.75 | 2019 | |
| Sanofi-Aventis U.S. LLC | $33.56 | 2022 | |
| Novartis Pharmaceuticals Corporation | $26.08 | 2020-2023 | |
| Cvrx, INC. | $20.64 | 2024 | Barostim Neo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.56 | 2025 | Lifevest |
| Actelion Pharmaceuticals US, INC. | $17.44 | 2020 | |
| Janssen Pharmaceuticals, INC | $12.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Langhorne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.